Alessandra Oliva

Pubblicazioni

Titolo Pubblicato in Anno
Efficacy of Fosfomycin-Containing Regimens in Treating Severe Infections Caused by KPC-Producing Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2024
Antibiotic-loaded hydrogel for the treatment of lower-limb fracture-related infections: a single center’s multidisciplinary experience GELS 2024
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route VACCINES 2024
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection CIRCULATION RESEARCH 2023
Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University hospital in Rome BMC PULMONARY MEDICINE 2023
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients INTERNAL AND EMERGENCY MEDICINE 2023
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study CLINICAL AND EXPERIMENTAL MEDICINE 2023
Endothelial dysfunction, oxidative stress and low-grade endotoxemia in COVID-19 patients hospitalised in medical wards. MICROVASCULAR RESEARCH 2023
Genome-based retrospective analysis of a Providencia stuartii outbreak in Rome, Italy. Broad spectrum IncC plasmids spread the NDM carbapenemase within the hospital ANTIBIOTICS 2023
Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study OPEN FORUM INFECTIOUS DISEASES 2023
Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy EMERGING INFECTIOUS DISEASES 2023
Risk factors for carbapenem-resistant Acinetobacter baumannii (crab) bloodstream infections and related mortality in critically ill patients with (crab) colonization JAC-ANTIMICROBIAL RESISTANCE 2023
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2023
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2023
Acinetobacter baumannii in the critically ill: complex infections get complicated FRONTIERS IN MICROBIOLOGY 2023
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2023
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended JOURNAL OF CLINICAL MEDICINE 2023
Did the updated Duke criteria missed Erysipelothrix rhusiopathiae from the list of typical microorganisms causing infective endocarditis? LE INFEZIONI IN MEDICINA 2023
Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin EXPERT REVIEW OF ANTI-INFECTIVE THERAPY 2023
First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2023

Interessi di ricerca

Nosocomial infections; clinical microbiology; multi-drug resistant pathogens; translational research; microbial translocation during infections

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma